Studiengruppe Bioanalytik

Bioanalysis is at the interface of all life sciences. The constant technical development of faster, cheaper, more accurate, and more sensitive methods for the detection of biomolecules has led to the fact that a large number of biomolecules such as proteins, DNA or metabolites can be examined from a single sample in a few hours to days. The large number of biomolecules that can be recorded allows holistic charting of biochemical processes. These developments are accompanied by new insights into complexity and regulation in biological systems. However, it is precisely this enormous diversity that increasingly indicates the need for new and improved methods of bioanalytics and bioinformatics - both for basic and for translational research.

The "Bioanalytics" study group was founded in 1980. The aim of the study group is to synergistically combine current developments in the field of bioanalytics with functional basic research in the GBM, so that the life sciences can benefit more from the power of bioanalytics.

In particular, the methods of metabolomics, lipidomics, proteomics, immunoassays, next-generation sequencing, and the corresponding imaging modalities are excellently covered directly by the study group spokespersons or their networks.

The experience of the study group is made available to other GBM members in annual workshops. This is intended to expand and transfer the know-how of the group. Furthermore, there is the possibility to organize laboratory rotations in the study group in order to give young scientists insights and access to the latest bioanalytical methods.


Speaker
Prof. Dr. Sven Heiles
ISAS e.V.
Otto-Hahn-Str. 6b
44227 Dortmund
P. +49 231 13924202

Deputy Speakers
Dr. Oliver Pötz
CEO
SIGNATOPE GmbH
Markwiesenstr. 55
72770 Reutlingen
P. +49 7121 7440861

Dr. Frederik Weiß
Boehringer Ingelheim Pharma GmbH & Co.
Birkendorfer Str. 65
88397 Biberach